1. NTPDase5/PCPH as a New Target in Highly Aggressive Tumors: A Systematic Review
   Paula Andreghetto Bracco et al, 2014, BioMed Research International CrossRef
2. miRNA Expression Signatures of Therapy Response in Squamous Cell Carcinomas
   János Tibor Fekete et al, 2020, Cancers CrossRef
3. Predicting human disease mutations and identifying drug targets from mouse gene knockout phenotyping campaigns
   Robert Brommage et al, 2019, Disease Models & Mechanisms CrossRef
4. ENTPD5 Induces Apoptosis in Lung Cancer Cells via Regulating Caspase 3 Expression
   Yijun Xue et al, 2015, PLOS ONE CrossRef
5. ENTPD5: identification of splicing variants and their impact on cancer survival
   Rafael Paschoal de Campos et al, 2021, Purinergic Signalling CrossRef
6. ENTPD5 splice variants: novel players in cancer?
   Francesca Arruga, 2021, Purinergic Signalling CrossRef
7. Knockdown of ENTPD5 inhibits tumor metastasis and growth via regulating the GRP78/p-eIF-2α/CHOP pathway in serous ovarian cancer
   Xueping Chen et al, 2022, Journal of Ovarian Research CrossRef
8. Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression
   Lisa Perilli et al, 2014, Oncotarget CrossRef
9. Biochemical analysis of ectonucleotidases on primary rat vascular smooth muscle cells and in silico investigation of their role in vascular diseases
   Ana Paula Santin Bertoni et al, 2020, Life Sciences CrossRef